INPLASY202630036

Network meta-analysis of first-line R-CHOP-based regimens in MYC/BCL2 double-expressor diffuse large B-cell lymphoma

Keywords: Double-expressor lymphoma; Diffuse large B-cell lymphoma; Network meta-analysis; R-CHOP; Pola-R-CHP; Polatuzumab vedotin; MYC; BCL2; Progression-free survival; Systematic review.

Review Status: completed but not published